drug
as of 2026-07-01agomelatine
Agomelatine
MeSH C084711
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Central Institute of Mental Health, Mannheim
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
3
A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia
NCT05646264Phase 4Unknown
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
NCT01822418Phase 4Completed
KOLs & investigators
3
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
KOL
Mathias Zink, MD
personKOL score 6
Helge Frieling, Prof., MD
personKOL score 5
yizhenghui1971@163.com Yi, M.D
personKOL score —